-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Deferred Tax Assets, Gross history and growth rate from Q4 2016 to Q3 2024.
- NEUROONE MEDICAL TECHNOLOGIES Corp Deferred Tax Assets, Gross for the quarter ending September 30, 2024 was $19.2M, a 22.6% increase year-over-year.
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Growth (%)